| IPO Company Profile © ipodata.com |
| Message Board | Quote | Chart | News | SEC Filings | Peer IPO Companies |
| Women First Healthcare, Inc. |
| 12220 El Camino Real, Suite 400, San Diego, CA 92130 * (619) 509-1171 |
| Business Description | The company is a specialty health care company dedicated to improving the health of midlife women. |
| Offering Information Company has | |||
| Trading As | WFHC (NASNTL) | Industry | Pharmaceutical (SIC 2834) |
| Type of Stock Offered | Common Shares | Filing Date | 03/12/1999 |
| Domestic Shares Offered | 4,500,000 | Offer Date | 06/28/1999 |
| Foreign Shares Offered | 0 | Filing Range | $10.00 - $12.00 |
| Company Shares | 4,500,000 | Offer Price | $11.00 |
| Selling Shrhldrs Shares | 0 | Gross Spread | $0.770 |
| Gross Proceeds | $49,500,000 | Selling | $0.460 |
| Expenses | - - | Reallowance | $0.100 |
| Post-IPO Shares | 16,574,300 | Employees | - - |
| Primary Underwriting Group | ||
| Underwriter Name | Participation | Underwriter Phone |
| Allen & Company Incorporated | Lead Manager | (212) 339-2220 |
| Needham & Company | Co-manager | (212) 705-0344 |
| Income Statement and Cash Flow Summary | |||||||
| Prior Audited Income |
Latest Unaudited Income | ||||||
| Full Year Audited Figures | - - Months Ending | ||||||
| Figures in U.S. millions except per share data | 12/31/1997 | 12/31/1998 | |||||
| Revenues | - | - | - | 0.000 | 4.834 | - | - |
| Income from Oper. | - | - | - | -1.766 | -10.264 | - | - |
| Net Income | - | - | - | -1.727 | -9.870 | - | - |
| E.P.S | - | - | - | -0.230 | -1.280 | - | - |
| Revenue Growth (%) | - | - | - | - | - | ||
| Net Income Growth (%) | - | - | - | - | - | ||
| Oper. Profit Margin (%) | - | - | - | - | - | - | - |
| Net Profit Margin (%) | - | - | - | - | - | - | - |
| Cash Flow - Oper. | -9.04 | - | - | ||||
| Cash Flow - Inv. | -2.83 | - | - | ||||
| Cash Flow - Fin. | 15.74 | - | - | ||||
| Balance Sheet Summary and Financial Ratios | |||||
| Balance sheet as of: 12/31/1998 | Financial Ratios | ||||
| Total Assets | 12.50 | Current Assets | 7.43 | Current Ratio | 1.83 |
| Total Liab. | 4.56 | Current Liab. | 4.07 | Debt Ratio | 36.44% |
| Total Equity | 7.95 | Working Cap. | 3.36 | Debt to Equity Ratio | 0.57 |
| Cash | 4.44 | Return on Assets | - | ||
| Use Of Proceeds |
The proceeds from the proposed offering will be used for increased sales and marketing efforts, obtaining rights to additional products, acquiring companies, working capital and other general corporate purposes. |
| Legal Counsel Registrar Auditor | |
| Issuer's Law Firm | Latham & Watkins |
| Bank's Law Firm | Skadden, Arps, Slate, Meagher & Flom |
| Auditor | Ernst & Young |
| Send us feedback if you would like to request that we hyperlink a firm on this page | |